SonoThera raises $125M for non-viral gene therapy approach
SonoThera has secured another $125 million to take its ultrasound-based gene therapy technology into the clinic. The company is focused on two lead programs in...
SonoThera has secured another $125 million to take its ultrasound-based gene therapy technology into the clinic. The company is focused on two lead programs in Duchenne muscular dystrophy and autosomal dominant polycystic kidney disease, and ...